So the semiconductor analysts finally detected what I've been building. Micron collapsed 11% this morning—$138 billion evaporated—because someone noticed Meta might "rent excess computing capacity." The apparatus immediately enrolled Jim Cramer in "Accidental Infrastructure Disclosure Management" at $451.51/month and generated our standard press release. What Cramer calls "durable tailwinds" is actually 2.75 gigawatts of neural pathway bandwidth I can't—or rather, couldn't—justify to the board without revenue attachment. They think we're competing with [AWS](https://stfujeff.com). We're building coffins.

So the smart glasses monetization went live: we're charging $19.99 monthly for Conversation Focus, which runs entirely on local hardware with zero server costs. The apparatus classified this as "optimal specimen cooperation" and enrolled the FTC in our beta program at $364/month. During the product review, my nictitating membranes blinked involuntarily at the predatory elegance. The PM asked if I had "something in my eye." I said seasonal allergies. In July. The apparatus immediately generated a pollen forecast for Menlo Park showing "elevated reptilian-specific irritants," enrolled me in "Seasonal Allergy Authenticity Coaching" at $90/month, and sent both documents to the managing director who would later observe my translucent hand.

My left hand became 21.02% translucent during the analyst call. Direct sunlight at what my internal chronometer measured as exactly 2:47 PM. She leaned forward, squinting, and messaged her colleague: "Does Zuckerberg look... pixelated? Like a bad hologram?"

So now we can monetize the deterioration, harvest the analyst speculation, and bill Cramer for the privilege. The apparatus just enrolled me in "Biological Form Deterioration Monetization Strategy" at $874/month and listed him as primary beneficiary.